Characteristic of expression levels of HepPar-1, alpha-fetoprotein, cytokeratin 7 and 20 by the cells of cholangiocellular cancer in trephine biopsy of the liver
DOI:
https://doi.org/10.14739/2310-1210.2014.5.28794Keywords:
Сholangiocellular Carcinoma, Expression, HepPar 1, alpha-Fetoprotein (AFP), Cytokeratin 7, Cytokeratin 20Abstract
Aim. Expression level of immunohistochemical markers such as HepPar-1, AFP, CK7, CK20 and the area of immunopositive cells in cholangiocellular liver cancer, and their differences from hepatocellular carcinoma
Methods and results. Histopathological, histochemical and immunohistochemical research of trephine was determined in the liver in 90 patients with biopsy. Among them 53 patients had hepatocellular, 36 – сholangiocellular liver cancer, 1 patient had mixed hepato-cholangiocellular carcinoma. Level of expression of immunohistochemical markers of tumor cells and the area of immunopositive tumor cells in the tumor was determined by photo-digital morphometry. It was established that expression of α-fetoprotein is determined in 47.22% of patients with cholangiocellular liver carcinoma in tumor cells, when AFP-immunopositive cells represent 17,25 ± 9,67% of the total area of tumor cells. Positive expression of HepPar-1 cells in cholangiocellular liver cancer wasn’t detected (unlike hepatocellular carcinoma, when cytoplasmic expression of HepPar-1 by tumor hepatocytes is determined in 92.45% of cases). Expression of СK7 by cholangiocellular carcinoma cells was observed in 97.22% of patients, and the expression of CK20 – in 45.29% patients, immunopositive cells represent 43,55 ± 9,93% and 50,28 ± 16,35% of the tumor area, respectively. Medium strength correlation was determined between the level of AFP and CK7 expression by tumor cells in cholangiocellular carcinoma. Direct strong bond was determined between level of AFP and CK20 expression. Negative weak correlation was determined between the level of CK7 and CK20.
References
Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2012) MacSween's Pathology of the Liver. (6th edn). Edinburgh: Churchill Livingstone/Elsevier
Geller, S. A., & Petrovic, L. M. (2009) Primary and Metastatic Malignant Tumors of the Liver. Biopsy Interpretation of the Liver. (2nd ed.). Lippincott Williams & Wilkins (LWW).
Basturk, O., Farris, III A. V., & Adsay, N. V. (2010) Immunohistology of the Pancreas, Biliary Tract and Liver. Diagnostic immunohistochemistry: theranostic and genomic applications. (Ed. by D.J. Dabbs), (3rd ed.). Philadelphia: Saunders/Elsevier.
(2011) Liver Pathology/ An Atlas and Cjncise Guide (by A.A. Suriawinata, S.N. Thung). N.Y.: demosMEDICAL.
Suriawinata, A. A., Thung, S. N. (2011) Liver pathology: an atlas and concise guide. N.Y.: demosMEDICAL.
Rodyonov, S. Yu., Cherkasov, V. A., Malyutina, N. N., Orlov, O. A. (2004) Al'fa-fetoprotein [Alpha-fetoprotein]. Ekaterinburg: UrO RAN. [in Russian].
Petrov, S. V., Rajkhlin, N. T. (2004) Rukovodstvo po immunogistokhimicheskoj diagnostike opukholej cheloveka [Guidelines for the immunohistochemical diagnosis of human tumors]. Kazan': Titul. [in Russian].
Tuffakha, M. S. A., Hychka, S. H., & Husky, H. L. (2013) Immunogistokhimicheskaja diagnostika opukholej [Immunohistochemical diagnosis of tumors]. Kyiv: Intermed. [in Ukrainian].
Tumanskiy, V. A., Zubko, M. D. (2014) Gepatocellyulyarnaya karcinoma: osobennosti mikrostruktury i e`kspressii HepPar-1, al'fa-fetoproteina, citokeratinov 7 i 20 [Hepatocellular Carcinoma: Microstructure and Expression features of Hepatocyte Marker, Alpha-Fetoprotein, Cytokeratins 7 and 20 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma]. Patologiya, 1(30), 45–50. [in Ukrainian].
Lugli, A., Tornillo, L., Mirlacher, M., Bundi, M., Sauter, G., & Terracciano, L.M. (2004) Hepatocyte paraffin-1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 samples. Am J Clin Pathol., 122, 721–727.
Nomoto, K., Tsuneyama, K., Cheng, C., et al. (2006) Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype. Pathol Res Pract., 202, 71–76. doi: 10.1016/j.prp.2005.10.011.
Durnez, A., Verslype, C., Nevens, F., Fevery, J., Aerts, R., Pirenne, J., ey al. (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology., 49,138–151. doi: 10.1111/j.1365-2559.2006.02468.x.
AlMuhannadi, N., Ansari, N., Brahmi, U., Abdel Satir, A. (2011) Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material. Ann Hepatol, 10(4), 508–515.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
